Market Research Logo

Ulcerative Colitis Global Clinical Trials Review, H2, 2018

Ulcerative Colitis Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2018 provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
    • Table Figure 1: Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region (%), 2018*
    • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region, 2018*
    • Clinical Trials and Average Enrollment by Country
      • Table Figure 2: Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
      • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
      • Table Figure 3: Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
      • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
      • Table Figure 4: Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
      • Table Figure 5: Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
      • Table Figure 6: Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2018*
      • Table Figure 7: Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
      • Table Figure 8: Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Clinical Trials by G7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials
    • Table Figure 9: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2018*
    • Table Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2018*
  • Clinical Trials by Phase in G7 Countries
    • Table Figure 10: Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
    • Table Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Clinical Trials in G7 Countries by Trial Status
    • Table Figure 11: Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
    • Table Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Clinical Trials by E7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials
    • Table Figure 12: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2018*
    • Table Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2018*
  • Clinical Trials by Phase in E7 Countries
    • Table Figure 13: Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
    • Table Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Clinical Trials in E7 Countries by Trial Status
    • Table Figure 14: Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
    • Table Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Clinical Trials by Phase
    • Table Figure 15: Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase (%), 2018*
    • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase, 2018*
    • In Progress Trials by Phase
      • Table Figure 16: Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
      • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Clinical Trials by Trial Status
    • Table Figure 17: Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
    • Table Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Clinical Trials by End Point Status
    • Table Figure 18: Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
    • Table Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Subjects Recruited Over a Period of Time
    • Table Figure 19: Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
    • Table Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Clinical Trials by Sponsor Type
    • Table Figure 20: Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
    • Table Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Prominent Sponsors
    • Table Figure 21: Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
    • Table Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
    • Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials
      • Table Figure 22: Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
      • Table Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Prominent Drugs
    • Table Figure 23: Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
    • Table Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Latest Clinical Trials News on Ulcerative Colitis
    • Jul 20, 2018: Koutif Therapeutics Confirms Clinical Candidate Drug
    • Jul 19, 2018: New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
    • Jul 19, 2018: Abivax completes dosing in phase 2a proof-of-concept clinical trial of ABX464 in Ulcerative Colitis (ABX464-101)
    • Jul 12, 2018: Landos doses first subject cohort in Phase l trial of BT-11 for IBD
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
      • Table Figure 24: GlobalData Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report